1. Market Research
  2. > Therapy Industry

Cancer Immunotherapy Industry, April 2017 Market Reports from Top Publishers

You might be interested in: Therapy, Chemotherapy, Lung Cancer, Nuclear Medicine, Cancer, Infectious Disease, Leukemia, Pancreatic Cancer, Prostate Cancer.


 
1-10 of 21 reports for Cancer Immunotherapy

Purchase Reports From Reputable Market Research Publishers

Nivolumab Sales, Price Analysis, & Sales Forecast - 2017

Nivolumab Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Nivolumab Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Nivolumab worldwide and by countries in North America, Europe, Japan, BRIC, ...

Cancer Immunotherapy: Building on Initial Successes to Improve Clinical Outcomes

Cancer Immunotherapy: Building on Initial Successes to Improve Clinical Outcomes

  • $ 2495
  • Industry report
  • April 2017
  • by Insight Pharma Reports

This new report builds on our 2014 Insight Pharma Report, Cancer Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies. In that report, we focused on the major classes ...

Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022

Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022

  • $ 2400
  • Industry report
  • April 2017
  • by Kuick Research

“Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022” report gives comprehensive insight on clinical and non-clinical developments in the field of cancer immunotherapy. As per report ...

Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation

Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • March 2017
  • by GBI Research

Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation Summary Head and neck cancer (HNC) is the sixth most common malignancy worldwide, ...

Cancer Immunotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Cancer Immunotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Global Cancer Immunotherapy Market: Overview The growing incidences of cancer and a need to treat them is the key driver of the global immunotherapy market. The number of deaths occurring due to cance ...

Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market

Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market

  • $ 4995
  • Industry report
  • December 2016
  • by GBI Research

Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market Summary Cancer is a group of diseases characterized ...

Cancer Immunotherapy - Global Market Outlook (2016-2022)

Cancer Immunotherapy - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Cancer Immunotherapy market is estimated at $54.35 billion in 2015 and is expected to reach $147.25 billion by 2022 growing at a CAGR of 15.3% from 2015 to 2022. ...

Cancer Immunotherapy Market by Type, Application, End User - Global Forecast to 2021

Cancer Immunotherapy Market by Type, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer, ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Cancer Immunotherapy: Analytical Tool

Cancer Immunotherapy: Analytical Tool

  • $ 8750
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

About 2600 reports for Cancer Immunotherapy

Download Unlimited Documents from Trusted Public Sources

3Legs Resources Plc - Annual Report, 2016

  • January 2016
    117 pages
  • United Kingdom  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.